Skip to content
  • Thursday, 19 November 2026
  • 2:10 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • How most-favored-nation pricing is reshaping generic drug economics, according to Dr. Reddy’s finance director
Laboratory Automation & Robotics

How most-favored-nation pricing is reshaping generic drug economics, according to Dr. Reddy’s finance director

Lana Keisha Jul 23, 2026 0

The landscape of generic drug economics in the United States is undergoing a significant transformation, largely driven by the advent…

Read More
Laboratory Automation & Robotics

How most-favored-nation pricing is reshaping generic drug economics, according to Dr. Reddy’s finance director

Lana Keisha Jul 15, 2026 0

The United States, long an outlier in global pharmaceutical pricing, is undergoing a profound transformation in its drug cost landscape,…

Read More
Laboratory Automation & Robotics

How most-favored-nation pricing is reshaping generic drug economics, according to Dr. Reddy’s finance director

Lana Keisha Jul 8, 2026 0

The U.S. pharmaceutical landscape, historically characterized by higher drug prices compared to other developed nations, is undergoing a significant transformation,…

Read More
Laboratory Automation & Robotics

Canada approves generic semaglutide from Dr. Reddy’s, a G7 first enabled by Novo Nordisk’s lapsed CAD$250 patent

Lana Keisha Jul 4, 2026 0

In a landmark decision poised to reshape access to one of the world’s most sought-after medications, Health Canada has granted…

Read More
Laboratory Automation & Robotics

How most-favored-nation pricing is reshaping generic drug economics, according to Dr. Reddy’s finance director

Lana Keisha Jun 30, 2026 0

The United States healthcare system, grappling with persistently high drug costs, has seen significant shifts in its economic landscape, particularly…

Read More
Laboratory Automation & Robotics

Canada approves generic semaglutide from Dr. Reddy’s, a G7 first enabled by Novo Nordisk’s lapsed CAD$250 patent

Lana Keisha Jun 26, 2026 0

In a landmark decision poised to reshape access to one of the world’s most in-demand medications, Health Canada has granted…

Read More
Laboratory Automation & Robotics

Canada approves generic semaglutide from Dr. Reddy’s, a G7 first enabled by Novo Nordisk’s lapsed CAD$250 patent

Lana Keisha Jun 18, 2026 0

The pharmaceutical landscape for diabetes and weight management medications has undergone a significant shift with Health Canada’s authorization of Dr.…

Read More
Laboratory Automation & Robotics

Canada approves generic semaglutide from Dr. Reddy’s, a G7 first enabled by Novo Nordisk’s lapsed CAD$250 patent

Lana Keisha May 21, 2026 0

The Canadian healthcare landscape is poised for a significant transformation with Health Canada’s authorization of Dr. Reddy’s Laboratories’ generic semaglutide…

Read More
TWiV 1286: Clinical Update with Dr. Daniel GriffinEnvironmental DNA Reveals Diverse and Depth-Stratified Biodiversity in East Indian Ocean Submarine CanyonsThis breakthrough could finally unlock male birth controlEngineered exosomes from pig semen: a high-yield platform for non-invasive ocular drug delivery
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Vertex Pharmaceuticals Extends Precision Medicine Alliance with Genomics in Four-Year Deal Valued at Over $220mBridging gaps in rare disease drug access requires strategic rethink  – Pharmaceutical TechnologyPrecision CRISPR-Activation in Brain Organoids Uncovers Promising Early Targets to Intercept Autism Spectrum Disorder DevelopmentSomething strange is living beneath the skin of deep-sea pigs
YOU MAY HAVE MISSED
Pharmaceutical R&D
Vertex Pharmaceuticals Extends Precision Medicine Alliance with Genomics in Four-Year Deal Valued at Over $220m
Teuku Ryan Nov 19, 2026
Pharmaceutical R&D
Bridging gaps in rare disease drug access requires strategic rethink  – Pharmaceutical Technology
Teuku Ryan Nov 19, 2026
Biotech & Genetic Research
Precision CRISPR-Activation in Brain Organoids Uncovers Promising Early Targets to Intercept Autism Spectrum Disorder Development
Jia Lissa Nov 19, 2026
Molecular & Cell Biology
Something strange is living beneath the skin of deep-sea pigs
Angie Faith Nov 19, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ